Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of metformin (MET) combined with adult stem cells in preparing medicine for treating myocardial infarction (MI)

An adult stem cell and combined adult technology, which is applied in drug combinations, medical preparations containing active ingredients, pharmaceutical formulations, etc., can solve the problems of limiting the efficacy of myocardial infarction and low survival rate, and achieve the effect of increasing survival and improving ability.

Inactive Publication Date: 2017-02-15
THE THIRD AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIV OF PLA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the low survival rate of CDC after transplantation greatly limits its efficacy in the treatment of myocardial infarction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of metformin (MET) combined with adult stem cells in preparing medicine for treating myocardial infarction (MI)
  • Application of metformin (MET) combined with adult stem cells in preparing medicine for treating myocardial infarction (MI)
  • Application of metformin (MET) combined with adult stem cells in preparing medicine for treating myocardial infarction (MI)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Extraction, Culture and Identification of Cardiosphere-derived Cells (CDC)

[0019] 16-week-old C57 mice (C57BL / 6-Tg(CAG-EGFP)C14-Y01-FM131Osb) were labeled with GFP, the isolated heart of the mouse was taken, and the mouse heart was cut into pieces smaller than 1mm 3 The tissue block was digested with 0.05% trypsin, and then the tissue was seeded in a 60mm small dish pre-incubated with fibronectin, and then 1ml of CEM (80% IMDM, 20% serum, 1% double antibody) was added, and the trypsin was used 7 days later. The incubated CDCs were digested enzymatically.

[0020] Centrifuge the above CDC cells at 1000r / min for 3min, discard the supernatant medium, wash twice with PBS, add CD29, CD105, CD90, CD45, CD34, CD31 antibodies, and FITC and PE isotype antibodies and incubate at 4°C for 30min, then PBS Wash twice, use C6 flow cytometer to identify, and the sample volume is 10000. The identification results were positive for CD29, CD105, and CD90, and negative for CD45, CD34, ...

Embodiment 2

[0022] Metformin (MET) combined with CDC can improve cardiac function in mice after myocardial infarction

[0023] Mice were randomly divided into four groups: MI+PBS, MI+MET, MI+CDC and MI+MET+CDC. Metformin 125 mg / kg was injected intraperitoneally 6 hours before myocardial infarction. After induction of anesthesia by isoflurane, the mice were fixed on a heating blanket, the skin and muscles of the neck were cut longitudinally, the trachea was exposed, and the trachea was intubated. The skin and muscles were cut transversely in the fourth intercostal space of the mouse, the ribs were exposed, the intercostal muscles were cut open, the heart was exposed with a spreader, the pericardium was torn, and the coronary artery was ligated 2-3mm below the left atrial appendage with 7-0 silk thread. Seeing that the color of the heart turned white, it indicated that the ligation was successful. In the experimental group, CDC was injected at 8 points at the edge of the myocardial infarct...

Embodiment 3

[0025] Metformin promotes CDC survival and reduces infarct size

[0026] Extract the cardiomyocytes of each group of mice in Example 2 and count the CDCs with green fluorescence under a microscope, specifically as follows: take the isolated hearts of mice in each group, place them in PBS at 4°C, and move them under the microscope; remove them with ophthalmic forceps For fat and other tissues around the aorta, quickly hang the aorta on the needle and tie it with a thread to fix it. The position of the needle should not exceed the root of the aorta; inhale No. 4mM KCl, 1mM MgCl 2 .6H 2 0, 10mM Hepes, 10mM taurine, 10mM BDM) to flush out the blood in the heart; remove the needle, hang it on the perfusion device, remove the air bubbles in the perfusion device, perfuse with No. 1 solution for 2min, and then change No. 2 solution ( 50ml No. 1 solution, 50mg collagenase, 6mg trypsin, 0.5M CaCl 2 2uL) to wash and digest for 10 minutes until the heart tissue becomes soft and collap...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of MET combined with adult stem cells in preparing a medicine for treating MI, and belongs to the field of biotechnology. The medicine prepared from MET combined with the adult stem cells is used for treating MI, so that the survival of the adult stem cells in a bad cardiac transplantation environment can be effectively increased, and the ability of the adult stem cells for myocardial repair and curative effect on MI treatment are improved.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to the application of metformin combined with adult stem cells in the preparation of drugs for treating myocardial infarction. Background technique [0002] Myocardial infarction (MI) is a serious heart disease that threatens the health of all human beings. The main pathogenesis of myocardial infarction lies in the acute and chronic loss of cardiomyocytes, which eventually leads to heart failure. Various types of stem cells including those derived from bone marrow and adipose tissue have been used in clinical trials to treat myocardial infarction, but the therapeutic effect is not very significant. The important reason is that the survival rate of stem cells after transplantation is low. In the environment of high inflammatory factors and free radicals in the host myocardial infarction area, no matter which type of stem cells are used for transplantation, the protection and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28A61K35/15A61P9/10A61K31/155
Inventor 王伟付文斌廖巧廖翔杨德忠曾春雨
Owner THE THIRD AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIV OF PLA